Do [ Clinical and pathological characterization of the overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis ]?
The overlap syndrome group showed combined features of both PBC and AIH. There were differences in clinical aspects, serology and histology between the overlap syndrome and pure PBC groups.
miR-378a-3p suppresses HSC activation, at least in part, via targeting of Wnt10a, supporting its potential utility as a novel therapeutic target for liver fibrosis.